2,4-thiazolidinedione has been researched along with Peripheral Arterial Disease in 1 studies
thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.
Peripheral Arterial Disease: Lack of perfusion in the EXTREMITIES resulting from atherosclerosis. It is characterized by INTERMITTENT CLAUDICATION, and an ANKLE BRACHIAL INDEX of 0.9 or less.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Walker, KL | 1 |
| Walsh, DB | 1 |
| Goodney, PP | 1 |
| Connell, SA | 1 |
| Stone, DH | 1 |
| Powell, RJ | 1 |
| Rzucidlo, EM | 1 |
1 other study available for 2,4-thiazolidinedione and Peripheral Arterial Disease
| Article | Year |
|---|---|
Retrospective review of superficial femoral artery stenting in diabetic patients: thiazolidinedione use may decrease reinterventions.
Topics: Aged; Diabetic Angiopathies; Female; Femoral Artery; Humans; Hypoglycemic Agents; Male; Middle Aged; | 2014 |